重定位抗胺剂埃巴斯作为细胞内siRNA递送增强剂
Cristina Muntean1, Eva Blondeel2, Laure Harinck1
1Ghent Research Group on Nanomedicines, Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
International journal of pharmaceutics
|August 26, 2023
概括
乙巴斯是一种抗胰岛素,显著增强了小干扰RNA (siRNA) 输送到癌细胞中的作用. 这增强了基因沉默疗法,改善了非小细胞肺癌的治疗结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 小干扰RNAs (siRNAs) 是强大的基因沉默剂,但需要高效的细胞质递送才能获得治疗效果.
- 目前的siRNA传递方法往往无法逃离内体,导致溶酶体降解和降低有效性.
- 阴阳性两性药物 (CAD) 可以通过透内体/溶体膜来增强细胞质的传递.
研究的目的:
- 评估抗素CAD的ebastine,作为非小细胞肺癌 (NSCLC) 中siRNA传递和基因沉默的潜在增强剂.
- 将ebastine的疗效与其他CAD进行比较,并评估其与各种siRNA配方的性能.
主要方法:
- 在2D和3DNSCLC模型中使用聚合纳米凝和胆固醇结合siRNA研究了ebastine对siRNA传递的影响.
- 评估了ebastine对具有特定脂质和PEGylation特征的脂质纳米粒子 (LNP) 配方的影响.
- 量化siRNA介导的基因沉默效率和基因淘汰.
主要成果:
- 埃巴斯提高了聚合物纳米凝的siRNA介导基因沉默效率40倍.
- 埃巴斯在2D培养物和3D瘤球体中显著增强了胆固醇结合siRNA的基因淘汰.
- 埃巴斯证明了对先进的LNP配方的siRNA传递的强有力的增强,性能优于当前的标准.
结论:
- 埃巴斯被认为是癌细胞中siRNA传递的高效和多功能增强剂.
- 埃巴斯能够改善siRNA的细胞质释放,这在瘤学中是一个有前途的组合治疗策略.
- 这一发现为开发更有效的基于siRNA的癌症治疗开辟了新的途径.
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K


